Differential effects of 1,25-(OH)(2)D-3 and 19-nor-1,25-(OH)(2)D-2 on calcium and phosphate resorption in bone.

被引：0
|
作者：
Finch, JL [1 ]
Brown, AJ [1 ]
Slatopolsky, E [1 ]
机构：
[1] WASHINGTON UNIV, ST LOUIS, MO USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A2669 / A2669
页数：1
相关论文
共 50 条
  • [1] A new analog of 1,25-(OH)(2)D-3, 19-NOR-1,25-(OH)(2)D-2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content
    Takahashi, F
    Finch, JL
    Denda, M
    Dusso, AS
    Brown, AJ
    Slatopolsky, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) : 105 - 112
  • [2] The relative potencies of 1,25-(OH)2D3 and 19-Nor-1,25(OH)2D2 on intestinal calcium and phosphorus absorption.
    Finch, JL
    Slatopolsky, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S304 - S304
  • [3] Relative potencies of 1,25-(OH)2D3 and 19-Nor-1,25-(OH)2D2 on inducing differentiation and markers of bone formation in MG-63 cells
    Finch, JL
    Dusso, AS
    Pavlopoulos, T
    Slatopolsky, EA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (07): : 1468 - 1474
  • [4] Differential effects of 19-nor-1,25-(OH)2 D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats
    Slatopolsky, E
    Cozzolino, M
    Finch, JL
    KIDNEY INTERNATIONAL, 2002, 62 (04) : 1277 - 1284
  • [5] Paricalcitol [19-Nor-1,25-(OH)2D2] in the treatment of experimental renal bone disease
    Jokihaara, J
    Pörsti, I
    Pajamäki, I
    Vuohelainen, T
    Jolma, P
    Kööbi, P
    Kalliovalkama, J
    Niemelä, O
    Kannus, P
    Sievänen, H
    Järvinen, TLN
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (05) : 745 - 751
  • [6] CALCIUM AND PLASMA 1,25-(OH)D-2 VITAMIN-D IN HEALTH
    GRAY, RW
    CALDAS, AE
    ADAMS, ND
    LEMANN, J
    CLINICAL RESEARCH, 1977, 25 (04): : A621 - A621
  • [7] EFFECTS OF 1,25-(OH)2VITAMIN-D3 (1,25-(OH)2D3) ON CIRCADIAN MINERAL PATTERNS IN HUMANS
    MARKOWITZ, ME
    ROSEN, JF
    MIZRUCHI, M
    CLINICAL RESEARCH, 1984, 32 (02): : A402 - A402
  • [8] Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia
    Slatopolsky, E
    Cozzolino, M
    Lu, Y
    Finch, J
    Dusso, A
    Staniforth, M
    Wein, Y
    Webster, J
    KIDNEY INTERNATIONAL, 2003, 63 (06) : 2020 - 2027
  • [9] HUMAN ARTICULAR CHONDROCYTES ACQUIRE 1,25-(OH)2VITAMIN-D3 (1,25-(OH)2D3) RECEPTORS IN CULTURE
    GOLDRING, MB
    BHALLA, AK
    WOJNO, W
    KRANE, SM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 93 - 93
  • [10] Mechanisms for the selective actions of two vitamin D analogs, 19-nor-1,25(OH)(2)D-2 and 22-OXA-1,25(OH)(2)D-3, on the parathyroid glands.
    Brown, AJ
    Finch, J
    Takahashi, F
    Ritter, CS
    Slatopolsky, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2660 - A2660
12345